Author(s):
Mohammed Sameera Bhanu, Vasudha Dadi, Srinivasa Rao Yarraguntla, Vara Prasad Rao K
Email(s):
vasudha4mpharm@gmail.com
DOI:
10.52711/0974-360X.2023.00180 
Address:
Mohammed Sameera Bhanu, Vasudha Dadi*, Srinivasa Rao Yarraguntla, Vara Prasad Rao K
Department of Pharmaceutical Analysis, Vignan Institute of Pharmaceutical Technology, Beside VSEZ, Duvvada, Visakhapatnam – 530049, Andhra Pradesh, India.
*Corresponding Author
Published In:
Volume - 16,
Issue - 3,
Year - 2023
ABSTRACT:
A simple, accurate, precise and robust reverse phase high performance liquid chromatographic (RP-HPLC) method was developed and validated for the simultaneous estimation of Bilastine and Monteleukast Sodium in bulk and pharmaceutical dosage form. Chromatographic separation was performed on an Zodiac sil RP C18 column (100mm × 4.6mm, 3µm) with mobile phase consist a mixture of 75:25% v/v acetonitrile: phosphate Buffer pH adjusted to 5.2 with ortho-phosphoric acid in an isocratic elution mode, at a flow rate of 1 ml/min. The detection was monitored at 272nm. The retention time of Monteleukast Sodium and Bilastine were found to be 3.668 min and 2.746 min respectively. Linearity range was found between 20-100µg/ml for Bilastine with correlation coefficient of 0.999 and 5-25µg/ml for Monteleukast Sodium with correlation coefficient of 0.999. This method was validated with respect to linearity, precision, accuracy, ruggedness, limit of detection, limit of quantification and robustness. This method was successfully applied for the simultaneous estimation of Bilastine and Monteleukast Sodium in bulk and pharmaceutical formulation.
Cite this article:
Mohammed Sameera Bhanu, Vasudha Dadi, Srinivasa Rao Yarraguntla, Vara Prasad Rao K. RP-HPLC Method for Quantification of Bilastine and Monteleukast Sodium in Pharmaceutical Dosage form. Research Journal of Pharmacy and Technology 2023; 16(3):1079-4. doi: 10.52711/0974-360X.2023.00180
Cite(Electronic):
Mohammed Sameera Bhanu, Vasudha Dadi, Srinivasa Rao Yarraguntla, Vara Prasad Rao K. RP-HPLC Method for Quantification of Bilastine and Monteleukast Sodium in Pharmaceutical Dosage form. Research Journal of Pharmacy and Technology 2023; 16(3):1079-4. doi: 10.52711/0974-360X.2023.00180 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2023-16-3-16
REFERENCES:
1. May RJ . Dolen WK. Management of Allergic Rhinitis: A Review for the Community Pharmacist. Clinical Therapeutics. 2017; 1(1): 1-10 .
2. Bousquet J. Schunemann HJ. Samolinski B. Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. Journal of Allergy and Clinical Immunology. 2012; 130(5): 1049-1062. doi: 10.1016/j.jaci.2012.07.053
3. The Indian Pharmacopoeia, Government of India, Ministry of Health and Family Welfare; 7th ed., The Indian Pharmacopeia Commission, Ghaziabad, 2018; 2681-2683.
4. Drug Information, CDSCO approval, 2020 December.
5. da Silva AT. Brabo GR. Marques ID. Bajerski L. Malesuik MD . Paim CD. UV Spectrophotometric Method for Quantitative Determination of Bilastine using Experimental Design for Robustness. Drug Analysis Research. 2017; 1: 38-43. https://doi.org/10.22456/2527-2616.79221
6. Prathyusha P. Sundararajan R. UV spectrophotometric method for determination of Bilastine in bulk and pharmaceutical formulation. Research Journal of Pharmacy and Technology. 2020; 13(2):933-938. DOI: 10.5958/0974-360X.2020.00176.6
7. Nazira S. Saad A. Zakaa A. Determination of Montelukast by New Spectrophotometric Method using Bromocresol Green. Research Journal of Pharmacy and Technology. 2021; 14(1):445-449. DOI: 10.5958/0974-360X.2021.00081.0
8. Vishnu PC. Kale AN. Polshettiwar AS. Sutar AS. Patel DM. Kuchekar BS. Derivative and Absorption Factor Spectrophotometric Estimation of Montelukast Sodium and Levocetirizine Dihydrochloride from Pharmaceutical Formulations. Research Journal of Pharmacy and Technology. 2011;4(3): 389-392.
9. Pallavi K . Babu PS. Validated UV Spectroscopic Method For Estimation of Montelukast Sodium From Bulk and Tablet Formulations. International Journal of Pharmaceutical Sciences. 2012; 1(2): 104-111.
10. Ahmed BE. Shalaby AA. and El-Tohamy M. Development And Validation of of HPLC Method for the Determination of Montelukast and Its Degradation Products in Pharmaceutical Formulation using an Experimental Design. Acta Pharmaceutica Sciencia. 2011; 53: 45- 56.
11. Prathyusha P. Sundararajan R. Bhanu P. Mukthinuthalapati MA. A new stability indicating RP-HPLC method for determination of Bilastine in bulk and pharmaceutical formulation. Research Journal of Pharmacy and Technology. 2020; 13(6): 2849-2853. DOI: 10.5958/0974-360X.2020.00507.7
12. Chowdary VA. Anusha K. Muneer S. Method Development and Validation of New RP-HPLC Method for the Estimation of Bilastine in Pharmaceutical Dosage Form. World Journal Pharmacy and Pharmaceutical Sciences. 2017; 6(8): 2297-2315.
13. Firdous S. Rizwan SH. Analytical Method Development and Validation for the Estimation of Bilastine in Bulk and Pharmaceutical Dosage Form By UPLC. World Journal of Pharmaceutical and Life Sciences. 2020; 6(10): 138-143.
14. Mastanaiah T. Reddy JS. Rao SNV. Reddannaa P. Stability Indicating Assay Method for Montelukast Sodium in Pharmaceutical Formulations by RP-HPLC. Journal of Pharmaceutical Sciences and Research. 2011; 3(8): 1373-1377.
15. Ouarezki R. Guermouche S. Guermouche MH. Degradation Kinetics of Bilastine Determined by RP-HPLC method and Identifcation of its Degradation Product in Oxidative Condition. Slovak Academy of Sciences. 2019 ;2(4): 23-29. DOI:10.1007/s11696-019-00956-x
16. Rambabu K. Murty SN. Ramasrinivas. Rao GN. Stability Indicating Method Development and Validation for the Determination of Bilastine And its impurities by UPLC Method. International Journal of Pharmaceutical Sciences and Research. 2020; 11(3): 1312-1321.doi: 10.13040/IJPSR.0975-8232.11(3).1312-21
17. Sachin G. Sanjay T. Omprakash B. RP-HPLC Method Development and Validation of Montelukast Sodium In Bulk Drug And Dosage Form. International Journal of Pharmacy and Biological Sciences. 2015; 6(2): 354 – 360.
18. Saeed-Ul-Hassan S. Ahsan-Ul-Haq A. Ansari MT . Tariq I. Karim S. Determination of Montelukast Sodium in Raw Material and Solid Dosage Form Using Reverse Phase HPLC. Asian Journal of Chemistry. 2013; 25(13): 7481-7484.
19. Baokar S. Nisharani R. Analytical Method Development and Validation for Simultaneous Estimation of Montelukast and Ebastine by HPLC. Research Journal of Pharmacy and Technology. 2015; 8(1): 1-5. DOI: 10.5958/0974-360X.2015.00001.3
20. Sankar SK. Baskar GN. Nagavalli D. Anandakumar K. Vetrichelvan T. Simultaneous Estimation of Montelukast Sodium and Levocetirizine Hydrochloride from Tablet Dosage Form. Research Journal of Pharmacy and Technology. 2009;2 (4): 743-745
21. Chundawat RS. Sarangdevot YS. Rathore RPS. Sisodiya DS. Rathore US. Method Development and Validation for Simultaneous Estimation of Montelukast and Fexofenadine in Pharmaceutical Dosage Form by HPLC Method. Research Journal of Pharmacy and Technology. 2013; 6(10): 1102-1106.
22. Tamilselvi N. Sruthi K. Arivukkarasu R. Vanathi P. Visakh D. Development of Validated HPTLC Method for Simultaneous Estimation of Fexofenadine Hydrochloride and Montelukast Sodium in Tablet Dosage form. Research Journal of Pharmacy and Technology. 2016; 9(4): 469-473. DOI: 10.5958/0974-360X.2016.00087.1
23. Raj RM. Sankar ASK . Vetrichelvan T. Analytical Method Development and Validation for Simultaneous Estimation of Bilastine and Montelukast Sodium by UV Spectrophotometry. World Journal of Pharmacy and Pharmaceutical Sciences. 2021; 10(1), 680-687.
24. Kumar TH . Asha C. New Validated Stability Indicating RP-HPLC Method For Simultaneous Estimation of Amlodipine Besylate and Valsartan in Pharmaceutical Formulation. International Journal of Pharmaceutical Sciences and Research. 2019; 10(5) : 2633-2643.
25. Kumar TH. Asha C. Sankar DG. Estimation of Amlodipine Besylate and Irbesartan in Pharmaceutical Formulation by RP-HPLC with Forced Degradation Studies. International Journal of Applied Pharmaceutics. 2019;11(33): 159-167.
26. Kumar TH. Begum A. Sankar DG. RP-HPLC Method for Determination of Azilsartan Medoximil and Chlorthalidone Tablets Exposed to Forced Degradation Condition, Biomedical Research. 2019; 30(5): 775-785.
27. Thoddi P. Kumar G. Gautam CH. Narasimha Raju BH. A Stability-Indicating UPLC Method for Simultaneous Quantification of Epalrestat and Pregabalin in Bulk and Marketed Formulations. Research Journal of Pharmacy and Technology. 2022; 15(1):206-210. DOI: 10.52711/0974-360X.2022.00034
28. Agarwal P. Kumari B. Sangeeta . Kumar M. Development of High Performance Liquid Chromatographic Estimation of Domperidone and Lansoprazole. Research Journal of Pharmacy and Technology. 2021; 14(12):6475-6478. DOI: 10.52711/0974-360X.2021.01119